Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-20
1996-04-16
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546115, 546167, C07D40104, C07D40114, A61K 3147
Patent
active
055084060
ABSTRACT:
The invention relates to new 4-quinolyl-dihydropyridine esters of the general formula (I) ##STR1## in which R.sub.1 to R.sub.6 have the meaning given in the description, to processes for their preparation and to their use in medicaments, especially in agents for the treatment of cardiac circulatory disorders.
REFERENCES:
patent: 4145432 (1979-03-01), Sato
patent: 4248873 (1981-02-01), Bossert et al.
patent: 5100900 (1992-03-01), Stoltefuss et al.
patent: 5204472 (1993-04-01), Stoltefuss et al.
P. G. Baraldi, et al., Collect Czech Chem. Commun. "Synthesis and Calcium Antagonist Activity of Dialkykl 1,4-Dimethyl-4-(Nitrogenous Heteroaryl)-3,5-Pyridine Dicarboxylates," vol. 57, pp. 169-178 (1992).
Bechem Martin
Goldmann Siegfried
Gross Rainer
Hebisch Siegbert
Hutter Joachim
Bayer Aktiengesellschaft
Springer David B.
LandOfFree
Quinolyl-dihydropyridine esters, processes for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolyl-dihydropyridine esters, processes for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolyl-dihydropyridine esters, processes for their preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326188